Varenicline
Product Images NDC 0378-5091

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Varenicline (NDC 0378-5091). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Varenicline Tablets 0.5 mg Bottle Label (Image 01)

Varenicline Tablets 0.5 mg Bottle Label (Image 01)
Each film-coated tablet contains 0.855 mg of varenicline tartrate. The usual dosage information should be referenced from the accompanying prescribing information. It is essential to keep this medication out of the reach of children. For storage, maintain at 20° to 25°C (68° to 77°F) following USP Controlled Room Temperature guidelines. Manufactured for Mylan Pharmaceuticals Inc. in Morgantown, WV, USA. The medication is the equivalent of 0.5 mg varenicline free base. The tablets carry the NDC 0378-5089-73 code. When dispensing, use a tight, light-resistant container with a child-resistant closure. Pharmacists should provide the accompanying Medication Guide to each patient. The packaging includes space for variable data coding and printing of LOT and EXP details.*
FDA Label Image

Varenicline Tablets 1 mg Bottle Label (Image 02)

Varenicline Tablets 1 mg Bottle Label (Image 02)
This is not available.*
FDA Label Image

Varenicline Tartrate Structural Formula (Image 03)

Varenicline Tartrate Structural Formula (Image 03)
FDA Label Image

Figure 1: Continuous Abstinence, Weeks 9 Through 12 (Image 04)

Figure 1: Continuous Abstinence, Weeks 9 Through 12 (Image 04)
FDA Label Image

Figure 2: Continuous Abstinence, Weeks 9 Through 52 (Image 05)

Figure 2: Continuous Abstinence, Weeks 9 Through 52 (Image 05)
FDA Label Image

Figure 3: Continuous Abstinence Rate During Nontreatment Follow-up (Image 06)

Figure 3: Continuous Abstinence Rate During Nontreatment Follow-up (Image 06)
This appears to be a table showing the continuous abstinence rates for individuals receiving Varenicline 10mg BID and Placebo over a period of weeks. The data suggests a comparison of abstinence rates between the two groups.*
FDA Label Image

Varenicline Tablets 0.5 mg And 1 mg Carton Label (Image 07)

Varenicline Tablets 0.5 mg And 1 mg Carton Label (Image 07)
This text provides information about a medication called varenicline in tablet form. It includes details about the dosage regimen, the manufacturer (Mylan Pharmaceuticals Inc.), storage instructions, and a reference to accompanying prescribing information and Medication Guide. The tablets contain varenicline tartrate, with different dosages for different days ranging from 0.5 mg to 1 mg. The text also mentions a Starting Month Box, which contains tablets for the first 4 weeks of treatment. Overall, it serves as guidance for the use and administration of varenicline tablets.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.